{"preliminary_commentary":{"by_channel":{"x_thread":9,"podcast":1},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT00450411\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"commentary_summary":null,"drugs_tested":[],"indication":"locally recurrent prostate cancer after external beam radiotherapy","name":"RTOG-0526","nct_id":"NCT00450411","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=rtog-0526-nct00450411. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Prostate brachytherapy delivered using either 125-iodine (I-125) or 103-palladium (Pd-103)","label":"Brachytherapy","type":"EXPERIMENTAL"}],"collaborators":["National Cancer Institute (NCI)","NRG Oncology"],"completion_date":{"date":"2022-05-20","type":"ACTUAL"},"conditions":["Prostate Cancer"],"enrollment":{"count":100,"type":"ACTUAL"},"has_results":true,"interventions":[{"name":"125-Iodine","otherNames":["brachytherapy"],"type":"RADIATION"},{"name":"103-palladium","otherNames":["brachytherapy"],"type":"RADIATION"}],"last_update":"2022-06-21","lead_sponsor":"Radiation Therapy Oncology Group","official_title":"A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy","overall_status":"COMPLETED","phases":["PHASE2"],"primary_completion_date":{"date":"2016-06","type":"ACTUAL"},"primary_outcomes":[{"measure":"Number of Patients With Late Treatment-related Gastrointestinal (GI) and Genitourinary (GU) Adverse Events (AE)","timeFrame":"Between 271 days and 730 days from date of implantation"}],"references":[{"citation":"Crook J, Rodgers JP, Pisansky TM, Trabulsi EJ, Amin MB, Bice W, Morton G, Murtha AD, Vigneault E, Helou J, Michalski JM, Roach M 3rd, Beyer D, Jani AB, Horwitz EM, Raben A, Pugh S, Sandler H. Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526). Int J Radiat Oncol Biol Phys. 2022 Apr 1;112(5):1115-1122. doi: 10.1016/j.ijrobp.2021.10.138. Epub 2021 Nov 3.","pmid":"34740768","type":"DERIVED"},{"citation":"Crook JM, Zhang P, Pisansky TM, Trabulsi EJ, Amin MB, Bice W, Morton G, Pervez N, Vigneault E, Catton C, Michalski J, Roach M 3rd, Beyer D, Jani A, Horwitz E, Donavanik V, Sandler H. A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526). Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):335-343. doi: 10.1016/j.ijrobp.2018.09.039. Epub 2018 Oct 9.","pmid":"30312717","type":"DERIVED"}],"start_date":{"date":"2007-05"},"study_type":"INTERVENTIONAL","title":"Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy","url":"https://clinicaltrials.gov/study/NCT00450411"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.1","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/rtog-0526-nct00450411"}